BriMonidine-2,3-dione(182627-95-8)
- Name: BriMonidine-2,3-dione
- Synonyms:BriMonidine-2,3-dione;Brimonidine Impurity J;Brimonidine Impurity 8 HCl;Brimonidine Impurity 1 HCl;Brimonidine 2,3-Dione Impurity;Brimonidine 2,3-Dione Impurity Hydrochloride;5-bromo-6-(4,5-dihydro-1H-imidazol-2-ylamino)-1,4-dihydroquinoxaline-2,3-dione;2,3-Quinoxalinedione, 5-bromo-6-[(4,5-dihydro-1H-imidazol-2-yl)amino]-1,4-dihydro-
- Molecular Formula:C11H10BrN5O2
- Molecular Weight:324.13
- CAS Registry Number:182627-95-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.182627-95-8 BriMonidine-2,3-dione
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.182627-95-8 Brimonidine Tartrate Impurity 1
Assay:> 95% Appearance:Tan Solid Package:inquiry Transportation:inquiry Application:Brimonidine Tartrate Impurity 1 is a metabolite of Brimonidine.
Min. Order:1Gram
Supplier:BOC Sciences [
United States]
Other Product
- 182576-20-1/4-Oxa-3,8,11,17-tetraazabicyclo[11.3.1]heptadeca-1(17),13,15-triene- 8-carboxylic acid, 1,1-dimethylethyl ester
- 182576-22-3/Carbamic acid, (2-aminoethyl)(3-aminopropyl)-, 1,1-dimethylethyl ester
- 182576-32-5/4-Oxa-3,8,11,17-tetraazabicyclo[11.3.1]heptadeca-1(17),13,15-triene- 8-carboxylic acid, 3,11-bis[(2-nitrophenyl)sulfonyl]-, 1,1-dimethylethyl ester
- 182576-33-6/3,7,12,18-Tetraazabicyclo[12.3.1]octadeca-1(18),14,16-triene
- 18257-78-8/Isoindolo[2,1-a]quinazoline-5,11-dione
- 1825-78-1/Silane, butoxydichloromethyl-
- 1825-79-2/Silane, dichloromethyl(1-methylpropoxy)-
- 1825-84-9/Silane, trichloro(1-methylethoxy)-
- 18258-63-4/Acetamide, 2,2-dichloro-N-(2-hydroxy-4-nitrophenyl)-
- 18259-39-7/1-Propanone, 2-(diethylamino)-1-(4-hydroxyphenyl)-
- 182615-10-7/1,3,5-Triazine-2,4,6-triamine, N,N',N''-tris[3,4-bis(hexadecyloxy)phenyl]-
- 18261-62-6/Phosphinic acid, (2-cyanoethyl)methyl-, ethyl ester
- 182616-54-2/Benzenamine, 2,2'-(phenylphosphinidene)bis-
- 182618-76-4/Carbamic acid, (5-cycloheptyl-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl)-, phenylmethyl ester
- 182618-88-8/Carbamic acid, (5-cycloheptyl-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin-3-yl)-, phenylmethyl ester
- 182621-36-9/2-Oxazolidinone, 3-[(2S,3R)-3-hydroxy-2-methyl-1-oxodecyl]-4-(phenylmethyl)-, (4S)-
- 182621-55-2/4-Piperidinamine, 1-acetyl-N-methyl-4-phenyl-
- 182626-16-0/1H-Benzimidazolium, 2-chloro-1,3-diethyl-, hexafluorophosphate(1-)
- 18262-63-0/Benzothiazolium, 2,3-dimethyl-6-nitro-, iodide
- 182627-95-8/BriMonidine-2,3-dione
- 182629-26-1/Silane, [3,5-bis(chloromethyl)phenoxy](1,1-dimethylethyl)dimethyl-
- 182629-51-2/Lithium, [dimethyl(5-methyl-2-furanyl)silyl]-
- 182631-21-6/Thieno[3,2-f]quinoline-2-methanol
- 182631-23-8/Benzamide, N-[1-phenyl-5-(trifluoromethyl)-1H-benzimidazol-7-yl]-
- 182631-25-0/Thieno[3,2-f]quinoline, 2-(chloromethyl)-
- 182631-27-2/Phosphonium, triphenyl(thieno[3,2-f]quinolin-2-ylmethyl)-, chloride
- 182631-93-2/1H-Benzimidazol-7-amine, 1-phenyl-5-(trifluoromethyl)-
- 182633-31-4/Benzoic acid, 3,5-bis(acetylamino)-2,4,6-triiodo-, 2,4-diethoxy-4-oxo-2-butenyl ester
- 18264-29-4/Phosphoric acid, 3-chlorophenyl dimethyl ester
- 18264-62-5/Benzene, 2,4-dichloro-1-[2-chloro-1-(4-chlorophenyl)ethenyl]-